InspireMD Expands with New Miami Headquarters
Company Announcements

InspireMD Expands with New Miami Headquarters

InspireMD ( (NSPR) ) has provided an announcement.

InspireMD, Inc. has established its global headquarters in Miami, Florida, marking a critical move to support the anticipated U.S. launch of its CGuard Prime carotid stent system in 2025. This new base is strategically located to leverage South Florida’s resources and talent pool, aiding in building a robust commercial and operational team to drive growth and expand market presence. As they gear up for potential FDA approval, InspireMD aims to capitalize on this expansion to enhance shareholder value and meet growing demand in the U.S. market.

Find detailed analytics on NSPR stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskInspireMD Achieves Record Q3 Revenue with CGuard Success
TheFlyInspireMD reports Q3 EPS (16c) vs (15c) last year
Catie PowersNSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App